tirzepatide phase 3 trial 80 weeks weight change Lilly's weight-loss drug reduces sleep apnea severity in late-stage trials The numbers from Lilly's Phase

Your future self will thank you.

Adenosine Monophosphate-Activated Protein Kinase Activation and Mammalian Target of Rapamycin Complex 1 Inhibition: A Mechanistic Rationale for Anti-Aging Therapy in Type 2 Diabetes

and Ida Green Professorship in System Biology (to J.Z.) from the University of Texas at Dallas

Choose MOTS-c if you want to improve metabolic function, support fat loss, or address age-related metabolic decline

MeAgain keeps your current step, the next shot countdown, the last logged dose, and the notes around each increase together in one treatment view

To understand these phenomena we developed a whole body model of glutamate and glutamine metabolism (Bilinsky et al